RecruitingNCT06582888
Studying varenicline, nicotine cues, and smoking behavior
About this title
Read the official source — NCT06582888Medication studyAges 22+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 22 years.
- Listed locations
- San DiegoSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 19, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- Over 22 Years
- Official registry ID
- NCT06582888
- Official title
Show the full official title
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Diego
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Does this study involve medication?
Yes. The study involves medication, including Varenicline Tartrate and Placebo.
Who can participate?
Listed age limits: from 22 years.
Is this study still recruiting?
The registry lists this study as recruiting.
